VISIODORON EUPHRASIA COMP. ong opht tb 5 g

7680688250015 CH-68825 20.02.
VISIODORON EUPHRASIA COMP. ong opht tb 5 g
VISIODORON EUPHRASIA COMP. ong opht tb 5 g
VISIODORON EUPHRASIA COMP. ong opht tb 5 g
1 / 3
google

Details

Product number
6882501
CPT
-
Packaging group
5
Unit
g
Composition
echinacea angustifolia e planta tota Rh TM (HAB 21) 30 mg, calendula officinalis e floribus cum calycibus paraffinum liquidum TM (HAB 57) 50 mg, euphrasia stricta et euphrasia officinalis e planta tota Rh TM (HAB 21) 50 mg, vaselinum album, paraffinum liquidum, aqua ad iniectabile, cholesterolum, ad unguentum pro 1 g.

Articles (1)

Visiodoron Euphrasia comp., Augensalbe
Augensalbe
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2024
Patient information leaflet
Français
01/05/2024
Patient information leaflet
Italien
01/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Weleda AG

4144 Arlesheim

Authorization information

Swissmedic authorization number
68825
Drug name
Visiodoron Euphrasia comp., Augensalbe
Galenic form
AUGS
Authorization status
Z
Dispensation category
D
First authorization
20/07/2023
Authorization expiration date
19/07/2028
IT number
20.02.
Domain
Human medicine
Field of application
Gemäss der anthroposophischen Menschen- und Naturerkenntnis bei Augenentzündungen wie Bindehautentzündung, Gerstenkorn, Hagelkorn und Lidrandentzündungen

Packaging details

Description (FR)
VISIODORON EUPHRASIA COMP., pommade ophtalmique 5g
Description (DE)
VISIODORON EUPHRASIA COMP., Augensalbe 5g
Market launch
20/07/2023
Narcotic (BTM)
No